Literature DB >> 6436821

Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies.

E Celis, V R Zurawski, T W Chang.   

Abstract

Eight mouse monoclonal antibodies specific for hepatitis B surface antigen (HBsAg) were examined for their effects on the antigen-induced proliferative response and lymphokine production of human HBsAg-specific T-cell clones in vitro. While all specifically enhanced the T-cell proliferative response, antibodies of the IgG class were generally more effective than those of the IgM class. Both the divalent F(ab')2 and the monovalent Fab fragments of an IgG monoclonal antibody had no effects, indicating that the Fc portion of the antibody molecules was required. Since antigen-presenting cells bear surface receptors for the Fc of IgGs and fewer or none for that of IgMs, the above results also suggest that antibodies enhance the capture of antigens by antigen-presenting cells as a result of the binding of antigen-antibody complexes to the Fc receptors on these cells. In addition to potentiating the proliferation of the T-cell clones, antibodies also increased the antigen-induced production of interferon-gamma by these cells. The present in vitro studies suggest that antibodies may regulate immune responses and do so by enhancing antigen presentation and thus augmenting antigen-induced activation and clonal expansion of T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436821      PMCID: PMC392029          DOI: 10.1073/pnas.81.21.6846

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Helper T cells recognise antigen and macrophage surface components simultaneously.

Authors:  J W Kappler; P C Marrack
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

2.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.

Authors:  L B Lachman; M P Hacker; R E Handschumacher
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

Review 4.  Endocytosis.

Authors:  S C Silverstein; R M Steinman; Z A Cohn
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

5.  Antigen-macrophage interaction. II. Relative roles of cytophilic antibody and other membrane sites.

Authors:  B E Cohen; A S Rosenthal; W E Paul
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

6.  Macrophage control of time-dependent changes in antigen sensitivity of immune T lymphocyte populations.

Authors:  B E Cohen; W E Paul
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

Review 7.  Regulatory effect of antibody on the immune response.

Authors:  J W Uhr; G Möller
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

8.  T-lymphocyte-enriched murine peritoneal exudate cells. II. Genetic control of antigen-induced T-lymphocyte proliferation.

Authors:  R H Schwartz; W E Paul
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

9.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  24 in total

1.  The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

Authors:  E Egea; A Iglesias; M Salazar; C Morimoto; M S Kruskall; Z Awdeh; S F Schlossman; C A Alper; E J Yunis
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

2.  DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.

Authors:  M Mancini; M Hadchouel; H L Davis; R G Whalen; P Tiollais; M L Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  In vitro induction of HBsAg-specific CD8 CD11 human suppressor T cells.

Authors:  V Barnaba; G Ruberti; M Levrero; F Balsano
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

4.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.

Authors:  K H Mills
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Presentation by peritoneal macrophages: modulation by antibody-antigen complexes.

Authors:  K A Perkins; B M Chain
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

7.  Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies.

Authors:  E Celis; T J Wiktor; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects.

Authors:  J L Ceuppens; M L Baroja; F Van Vaeck; C L Anderson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Induction of the in vitro anti-HBs response by hepatitis B surface antigen.

Authors:  L G Filion; R Saginur
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

Review 10.  Vaccine therapies for chronic hepatitis B: can we go further?

Authors:  Yumei Wen; Xuanyi Wang; Bin Wang; Zhenhong Yuan
Journal:  Front Med       Date:  2014-01-24       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.